Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
NSRXNasus Pharma Ltd
| Figure | NSRXNasus Pharma LtdFY2025 · Dec |
|---|---|
| Revenue | $1.24B |
| Revenue, yoy | — |
| Net income | $5.86M |
| Net income, yoy | −282.2% |
| Net margin | -0.5% |
| Free cash flow | $4.93M |
| FCF margin | -0.4% |
| EPS, diluted | $0.72 |
Add another company.
Annual · USD
No annual figures on file for this.
From SEC EDGARSame fiscal periods, as filed